Photo from E. Anders Kolb/LinkedIn
Mar 28, 2024, 00:14
E. Anders Kolb: LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group
E. Anders Kolb, President and CEO at The Leukemia and Lymphoma Society, recently posted on LinkedIn:
“As an early funder of research that led to the development of CAR-T cell therapy, The Leukemia & Lymphoma Society has longstanding expertise and commitment to immune-based therapies for treating blood cancers. LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group.”
View additional information.
Source: E. Anders Kolb/LinledIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 2, 2024, 17:53
Nov 2, 2024, 17:41
Nov 2, 2024, 15:31
Nov 2, 2024, 15:23